Loading
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Previous close
$0.774
+$0.0057 · +0.74%
Regular session · ET · Market data may be delayed.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Day range
Current $0.774
52-week range
Current $0.774
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
30
Expensive
Sentiment
53
Mixed
Risk
66
High Risk
Momentum
29
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Day range
Current $0.774
52-week range
Current $0.774
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8.27M USD | 8.74M USD | 8.86M USD | 8.54M USD | 7.92M USD |
| Cost of goods sold | 3.15M USD | 2.91M USD | 3.88M USD | 3.79M USD | 3.43M USD |
| Gross profit | 5.12M USD | 5.83M USD | 4.98M USD | 4.76M USD | 4.49M USD |
| Research and development | 2.71M USD | 3.21M USD | 5.42M USD | 4.34M USD | 4.98M USD |
| Selling, general, and administrative | 13.52M USD | — | 17.19M USD | 17.58M USD | 19.04M USD |
| Operating expenses | 16.23M USD | 16.81M USD | 22.61M USD | 21.93M USD | 24.02M USD |
| Interest expense | 10.55M USD | 5.61M USD | 3.48M USD | 9.25M USD | — |
| Depreciation and amortization | 417K USD | 310K USD | 362K USD | 372K USD | 488K USD |
| Operating income | −11.11M USD | −10.99M USD | −17.63M USD | −17.17M USD | −19.53M USD |
| Net income | −17.52M USD | −11.17M USD | −20.21M USD | −14.53M USD | −19.55M USD |
Company facts updated Sep 12, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jun 26, 2026 | 1:35 | — | — |
Stock split | Jul 7, 2025 | 1:42 | — | — |
Stock split | Jun 28, 2024 | 1:35 | — | — |
Stock split | Dec 12, 2022 | 1:100 | — | — |
Stock split | Oct 19, 2020 | 1:30 | — | — |
Stock split | Jan 3, 2019 | 1:14 | — | — |
Effective Jun 26, 2026
1:35
Effective Jul 7, 2025
1:42
Effective Jun 28, 2024
1:35
Effective Dec 12, 2022
1:100
Effective Oct 19, 2020
1:30
Effective Jan 3, 2019
1:14
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
